BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 2878541)

  • 21. [Intracellular signal systems in the epithelium- and endothelium-dependent relaxation of smooth muscles].
    Kapilevich LV; Kovalev IV; Baskakov MB; Medvedev MA
    Usp Fiziol Nauk; 2001; 32(2):88-98. PubMed ID: 11548593
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thimerosal, an inhibitor of endothelial acyl-coenzyme A: lysolecithin acyltransferase, stimulates the production of a nonprostanoid endothelium-derived vascular relaxing factor.
    Förstermann U; Goppelt-Strübe M; Frölich JC; Busse R
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17B():1108-11. PubMed ID: 2960154
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nitric oxide and regulation of vascular tone: pharmacological and physiological considerations.
    McHugh J; Cheek DJ
    Am J Crit Care; 1998 Mar; 7(2):131-40; quiz 141-2. PubMed ID: 9509227
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endothelium-derived relaxing and contracting factors.
    Vanhoutte PM; Eber B
    Wien Klin Wochenschr; 1991; 103(14):405-11. PubMed ID: 1926867
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The mechanisms and significance of the coupled release of endothelium-derived relaxing factor (EDRF) and prostacyclin (PGI2) from endothelial cells.
    Hyslop S; de Nucci G
    Wien Klin Wochenschr; 1991; 103(14):422-34. PubMed ID: 1926869
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The endothelium and arterial reactivity].
    Vanhoutte PM
    J Mal Vasc; 1986; 11(3):213-21. PubMed ID: 3490530
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Endothelial dysfunction and vascular pathology].
    Vanhoutte PM
    Bull Mem Acad R Med Belg; 2006; 161(10-12):529-36; discussion 536-7. PubMed ID: 17503729
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acetylcholine stimulates release of endothelium-derived relaxing factor in coronary arteries of human organ donors.
    Blaise GA; Stewart DJ; Guérard MJ
    Can J Cardiol; 1993 Nov; 9(9):813-20. PubMed ID: 8281481
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Inhibition of thrombocyte aggregation and adhesion by endothelium-derived relaxant factor (EDRF) and their pathophysiologic significance].
    Bassenge E; Busse R; Pohl U
    Z Kardiol; 1989; 78 Suppl 6():54-8. PubMed ID: 2515672
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Formation and functional importance of endothelium-derived relaxing factor (EDRF) and prostaglandins in the microcirculation.
    Förstermann U; Warmuth G; Dudel C; Alheid U
    Z Kardiol; 1989; 78 Suppl 6():85-91. PubMed ID: 2515674
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endothelium-dependent and nitrovasodilator-induced relaxation of vascular smooth muscle: role of cyclic GMP.
    Rapoport RM; Murad F
    J Cyclic Nucleotide Protein Phosphor Res; 1983; 9(4-5):281-96. PubMed ID: 6147363
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The role of endogenous free radicals of nitric oxide (NO)].
    Antoni F; Csuka I; Romics L
    Orv Hetil; 1992 Mar; 133(13):773-6. PubMed ID: 1560970
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LY 83583 interferes with the release of endothelium-derived relaxing factor and inhibits soluble guanylate cyclase.
    Mülsch A; Busse R; Liebau S; Förstermann U
    J Pharmacol Exp Ther; 1988 Oct; 247(1):283-8. PubMed ID: 2902213
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Abnormal endothelium-mediated regulation of vascular tone in arteriosclerosis].
    Mügge A
    Z Kardiol; 1994 Oct; 83(10):759-67. PubMed ID: 7528959
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The role of blood vessel endothelium in vascular smooth muscle reactivity to biologically active substances and drugs].
    Varalić VM; Prostran M; Jezdimirović M
    Srp Arh Celok Lek; 1989; 117(11-12):799-810. PubMed ID: 2490997
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence that S-nitrosothiols are responsible for the smooth muscle relaxing activity of the bovine retractor penis inhibitory factor.
    Kerr SW; Buchanan LV; Bunting S; Mathews WR
    J Pharmacol Exp Ther; 1992 Oct; 263(1):285-92. PubMed ID: 1357157
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Endothelial dysfunction and atherosclerosis].
    Vanhoutte PM
    Arch Mal Coeur Vaiss; 1997 Nov; 90 Spec No 6():9-19. PubMed ID: 9515109
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endothelium-dependent hyperpolarization of vascular smooth muscle cells.
    Félétou M; Vanhoutte PM
    Acta Pharmacol Sin; 2000 Jan; 21(1):1-18. PubMed ID: 11263241
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endothelium-derived relaxing factor is a selective relaxant of vascular smooth muscle.
    Shikano K; Berkowitz BA
    J Pharmacol Exp Ther; 1987 Oct; 243(1):55-60. PubMed ID: 3499504
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of YC-1, an NO-independent, superoxide-sensitive stimulator of soluble guanylyl cyclase, on smooth muscle responsiveness to nitrovasodilators.
    Mülsch A; Bauersachs J; Schäfer A; Stasch JP; Kast R; Busse R
    Br J Pharmacol; 1997 Feb; 120(4):681-9. PubMed ID: 9051308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.